Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians

Show other versions (1)

Bibliographic Details
Main Authors:	Chris J. Bushe MBBS, Nicola Savill
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-12-01
Series:	Journal of Central Nervous System Disease
Online Access:	http://www.la-press.com/atomoxetine-in-children-and-adolescents-with-attention-deficithyperact-a2938

Similar Items

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians
by: Chris J. Bushe Mbbs, et al.
Published: (2011-01-01)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
by: Clemow DB, et al.
Published: (2017-02-01)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
by: Paul Hammerness, et al.
Published: (2009-03-01)

A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?
by: Savill Nicola, et al.
Published: (2012-01-01)

Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
by: Su Jin Moon, et al.
Published: (2014-01-01)

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
by: Schacht Alexander, et al.
Published: (2010-12-01)

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
by: Tsutomu Nagai, et al.
Published: (2022-09-01)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
by: Rubin Richard, et al.
Published: (2009-12-01)

Atomoxetine induced hypomania in a patient with bipolar disorder and adult attention deficit hyperactivity disorder
by: Vijaya Kumar, et al.
Published: (2017-01-01)

Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
by: Reimherr Fred, et al.
Published: (2005-10-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder
by: Cao P, et al.
Published: (2018-11-01)

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder
by: Serkan Turan, et al.
Published: (2019-10-01)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
by: Dilla Tatiana, et al.
Published: (2009-04-01)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
by: Yoko Nakanishi, et al.
Published: (2017-05-01)

Attention-deficit/hyperactive disorder updates
by: Miriam Kessi, et al.
Published: (2022-09-01)

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
by: S King, et al.
Published: (2006-07-01)

Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
by: Satoshi Kasahara, et al.
Published: (2023-08-01)

Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders
by: Snircova E., et al.
Published: (2012-12-01)

Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine
by: Satoshi Kasahara, et al.
Published: (2022-07-01)

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
by: Imagawa H, et al.
Published: (2018-02-01)

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
by: Hanwella Raveen, et al.
Published: (2011-11-01)

An updated review on animal models to study attention-deficit hyperactivity disorder
by: Daegeon Kim, et al.
Published: (2024-04-01)

Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study
by: Huiya Mei, et al.
Published: (2022-02-01)

Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function
by: Wilfried Pott, et al.
Published: (2013-03-01)

Management of sleep disorders in autism spectrum disorder with co-occurring attention-deficit hyperactivity disorder: update for clinicians
by: Theodore Petti, et al.
Published: (2024-01-01)

Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
by: Satoshi Kasahara, et al.
Published: (2023-06-01)

Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies
by: Turgay Atilla, et al.
Published: (2011-05-01)

Atomoxetine Treatment of Attention Deficit/Hyperactivity Disorder Symptoms in 3–6-Year-Old Children with Autism Spectrum Disorder: A Retrospective Cohort Study
by: Hamza A. Alsayouf, et al.
Published: (2024-01-01)

Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates
by: Tae Hoon Eom, et al.
Published: (2024-01-01)

Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies
by: Johnston Josephine, et al.
Published: (2009-01-01)

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review
by: Katya Rubia, et al.
Published: (2021-08-01)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
by: Jadwiga Najib, et al.
Published: (2017-08-01)

Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats
by: Mahmoud H. Teaima, et al.
Published: (2023-02-01)

Attention deficit hyperactivity disorder.
by: Ramchandani, P, et al.
Published: (2003)

Attention deficit/hyperactivity disorder /
by: Dudley, William, 1964-
Published: (2005)

Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01)

Association between Attention Deficit Hyperactivity Disorder and the Autonomic Nervous System: An Update
by: Serhat Türkoğlu, et al.
Published: (2022-06-01)

A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder
by: Ashmita Chaulagain, et al.
Published: (2023-01-01)

A review of Cochrane reviews on pharmacological treatment for attention deficit hyperactivity disorder
by: Giovanna Marcílio Santos, et al.
Published: (2021-12-01)